The Board of The Biotech Growth Trust PLC announced the appointment of Hamish Baillie as an independent non-executive director of the Company, with effect from 1 November 2023. Mr. Baillie is a non-executive director of Mid Wynd International Investment Trust plc. His executive career was spent at Ruffer LLP, which he joined in 2002, becoming a partner in 2006.

Between 2011 and 2022 he was the Lead Manager of Ruffer Investment Company Ltd. He founded and managed the Edinburgh office of Ruffer and held firm-wide responsibilities in relation to portfolio management and investor communications. He was a member of the firm?s UK Wealth Leadership Team and a director of Ruffer (Channel Islands) Limited. He retired from Ruffer with effect from 3 October 2022.

Mr. Baillie has also been appointed to the Company?s Audit Committee, Management Engagement Committee, and Nominations Committee with effect from 1 November 2023. His appointment will be proposed to shareholders for election at the Annual General Meeting of the Company to be held in July 2024.